Deep learning in histopathology images for prediction of oncogenic driver molecular alterations in lung cancer: a systematic review and meta-analysis.
Journal:
Translational lung cancer research
Published Date:
May 30, 2025
Abstract
BACKGROUND: Lung cancer (LC) is the second most diagnosed cancer and the leading cause of cancer mortality worldwide. Non-small cell lung cancer (NSCLC) accounts for 85% of cases, with oncogenic alterations like , and guiding targeted therapies. Their prevalence varies by ethnicity, smoking status, and gender. Advances in artificial intelligence (AI) enable molecular biomarker prediction from hematoxylin and eosin-stained whole-slide images (H&E WSIs), offering a non-invasive approach to precision oncology. This review assesses deep learning (DL) models predicting oncogenic drivers in NSCLC from H&E WSIs and their diagnostic accuracy.
Authors
Keywords
No keywords available for this article.